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Objective: The potential contribution of CYP4A enzymes to endothelial dysfunction in Dahl salt - 
sensitive rats was determined by comparison to SS - 5BN consomic rats having chromosome 5 carrying 
CYP4A alleles from the BN rat introgressed into the SS genetic background. Methods: The following 
experiments were performed in cerebral arteries from HS - fed SS and SS - 5BN rats ± the SOD inhibitor 
DETC and/or the superoxide scavenger Tempol: (i) endothelial function was determined via video 
microscopy ± acute addition of the CYP4A inhibitor DDMS or Tempol; (ii) vascular oxidative stress was 
assessed with DHE fluorescence ± acute addition of DDMS, l - NAME, or PEG - SOD; and (iii) CYP4A 
protein levels were compared by western blotting. Results: In DETC - treated SS - 5BN and HS - fed SS 
rats, (i) DDMS or Tempol ameliorated vascular dysfunction, (ii) DDMS reduced vascular oxidative stress 
to control levels, (iii) chronic Tempol treatment reduced vascular CYP4A protein expression, and (iv) 
combined treatment with Tempol and l - NAME prevented the reduction in CYP4A protein expression 
in MCA of HS - fed SS rats. Conclusion: The CYP4A pathway plays a role in vascular dysfunction in SS 
rats and there appears to be a direct role of reduced NO availability due to salt - induced oxidant stress 
in upregulating CYP4A enzyme expression. 
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ROS reactive oxygen species 
SOD superoxide dismutase 
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SS - 13 BN SS - 13 BN consomic rats 
SS - 5 BN SS - 5 BN consomic rats (SS - Chr 5 BN /Mcwi strain) 
 
Introduction 
ROS are normal reactive by - products of oxygen metabolism that were originally considered to be 
universally damaging cellular molecules capable of producing injurious effects on lipids, proteins, and 
DNA.[ 1] However, it is now known that ROS also play an integral role in normal cell function including 
cellular metabolism, signaling, and regulation.[ 2] Under physiologic conditions, ROS are produced 
within the vasculature in a controlled manner, producing low concentrations of these vital signaling 
molecules, which play a role in normal vascular smooth muscle cell contraction[ 3] and growth.[ 4] ,[ 5] 
,[ 6] A pathophysiologic state ensues when there is either overproduction of ROS, a diminished 
capacity to regulate ROS concentrations due to reduced antioxidant defense mechanisms,[ 7] or both. 
20 - HETE is a vasoconstrictor metabolite of arachidonic acid that is formed endogenously in a number 
of vascular beds through the action of CYP4 enzymes of the 4A and 4F family.[ 8] ,[ 9] ,[ 10] ,[ 11] ,[ 12] 
20 - HETE appears to play a crucial role in the regulation of blood flow, O2 sensitivity, and vascular 
function.[ 8] ,[ 9] ,[ 10] ,[ 11] ,[ 12] The CYP4A/20 - HETE pathway can also contribute to oxidative stress 
in tissues because the action of the CYP4A enzyme requires the ROS - producing enzyme NADPH 
oxidase as a necessary cofactor.[ 13] 20 - HETE can also directly uncouple eNOS through a signaling 
cascade involving tyrosine kinase stimulation of the mitogen - activated protein kinase and 
extracellular signal - regulated kinase pathways.[ 14] This signaling cascade blocks the association 
between eNOS and HSP90, which is critical for the normal function of eNOS.[ 15] ,[ 14] ,[ 16] Thus, the 
CYP4A/20 - HETE pathway is not only involved in the direct production of ROS, but also in eNOS 
uncoupling, leading to reduced NO production and elevated vascular levels of superoxide anion (O2−). 
The Dahl SS rat is an inbred genetic model of salt - sensitive hypertension that is susceptible to 
heightened oxidative stress due, at least in part, to reduced antioxidant defense mechanisms. For 
example, Somova et al.[ 17] demonstrated decreased glutathione levels and reduced glutathione 
peroxidase activity (indicators of antioxidant defenses) in the myocardium of Dahl SS rats. Our 
laboratory and others have shown that Dahl SS rats have reduced levels of antioxidant enzymes 
including Cu/Zn - SOD in their cerebral vasculature,[ 18] as well as reduced renal medullary Cu/Zn - 
SOD and Mn - SOD expression.[ 19] Collectively, those findings are consistent with the hypothesis that 
Dahl SS rats have reduced antioxidant defense mechanisms, leaving them vulnerable to any 
mechanism that may generate reactive oxygen species. 
Previous studies in our laboratory have shown that cerebral arteries from SS rats exhibit a pathological 
upregulation of the CYP4A/20 - HETE pathway resulting in 20 - HETE - dependent vascular 
dysfunction.[ 20] Mesenteric resistance arteries from Sprague Dawley rats fed a high - salt diet also fail 
to dilate in response to reduced PO2—a response that can be restored in the presence of the CYP4A 
inhibitor DDMS.[ 21] The salt - induced vascular dysfunction in mesenteric resistance arteries of 
Sprague Dawley rats is due in part to elevated vascular CYP4A protein expression[ 21] and elevated 
vascular ROS, as evaluated via DHE fluorescence.[ 22] Thus, in both Dahl SS rats and HS - fed Sprague 
Dawley rats, an increase in CYP4A protein expression is observed concomitant with a highly oxidant 
environment suggesting that either the CYP4A/20 - HETE pathway is producing reactive oxygen species 
or, perhaps, that ROS levels are regulating the expression of the CYP4A/20 - HETE pathway. 
This study tested the hypothesis that upregulation of the CYP4A/20 - HETE pathway results in cerebral 
vascular dysfunction in the Dahl SS rat due to the production of ROS. We also evaluated whether 
elevated vascular ROS levels may upregulate the expression of the CYP4A/20 - HETE pathway in the 
vessels. This hypothesis was tested by comparing the Dahl SS rat to its close genetic counterpart, the 
SS - 5BN consomic rat, which has chromosome 5 carrying the 20 - HETE - producing CYP4A alleles from 
the normotensive BN rat introgressed into the SS genetic background. The SS - 5BN consomic rat is 
protected from salt - induced hypertension,[ 23] ,[ 24] vascular dysfunction, and vascular oxidative 
stress[ 20] that is present in the Dahl SS rat; and these protective effects of chromosomal substitution 
appear to be due, at least in part, to a decreased contribution of the CYP4A/20 - HETE pathway.[ 20] 
Materials and Methods 
Experimental groups 
Eight - to 12 - week - old male SS - 5BN consomic rats (SS - Chr 5BN/Mcwi strain) and Dahl SS rats were 
used for this study. Following weaning, Dahl SS rats were maintained on a normal salt (0.4% NaCl) diet 
and then switched to a high - salt (HS; 4.0% NaCl; Dyets, Inc., Bethlehem, PA, USA) diet for 3 days 
immediately prior to the experiments, with water to drink ad libitum. A subset of HS - fed Dahl SS rats 
were given drinking water with either the superoxide scavenger Tempol (1 mmol/L) alone or Tempol 
(1 mmol/L) and the nitric oxide synthase inhibitor NG - nitro - l - arginine methyl ester (l - NAME; 
40 mg/kg/day) for 7 days. Previous studies have shown that this duration and dosage of Tempol does 
not significantly alter blood pressure, regardless of salt intake.[ 25] 
The SS - 5BN consomic rats were divided into three treatment groups: (i) switched to a high - salt diet 
for 3 days; (ii) HS - fed SS - 5BN consomic rats receiving an i.v. infusion of the superoxide dismutase 
inhibitor, DETC at a low dose (16 mg/kg/day) for 7 days followed by 3 days of high dose of DETC 
(200 mg/kg/day); or (iii) the same conditions as Group 2 with Tempol in the drinking water for 7 days 
immediately prior to harvesting the vessels. The animals in Groups 2 and 3 were put on a HS diet for 
the final 3 days of the treatment session. The Medical College of Wisconsin IACUC approved all 
protocols. 
Isolated vessel experiments 
Animals were anesthetized with an intramuscular injection containing (in mg/kg): ketamine (75.0), 
acepromazine (2.5) and anased (10.0). MCA were isolated, cannulated with micropipettes, and 
perfused and superfused with bicarbonate - buffered physiological salt solution as described 
previously.[ 26] Internal diameter was measured using television microscopy, and vessels lacking active 
tone at rest were excluded from the study. 
After the control equilibration period, responses to the endothelium - dependent dilator ACh (10−10–
10−5 mol/L) were determined. The vessels were then incubated for 30 min in the presence of DDMS 
(50 μmol/L) to inhibit CYP4A enzymes and the responses to ACh were repeated. Time control 
experiments showed no effect of incubation time on vascular responses. In a second series of 
experiments, acute Tempol (100 μmol/L) was added to the perfusate and superfusate for the final 
30 minutes of the control equilibration period and the responses of the arteries to acetylcholine were 
then recorded. 
Vessel responses to an NO donor were not tested in the present study, because our earlier studies[ 20] 
showed that there is no difference in the response of MCA to an exogenous nitric oxide donor in Dahl 
SS and SS - 5BN rats fed either a normal salt or high - salt diet; and no effect of DDMS on vessel 
responses to NO donors. Because DDMS lowers vascular ROS levels similar to Tempol, we believe that 
vessel responses to SNP would also be unaffected by Tempol treatment, although this remains to be 
established. 
At the end of the experiment, the maximum diameter of the artery was determined by adding 
hydrogen peroxide (H2O2; 1.76 mmol/L) to the superfusate to achieve maximum dilation. Active resting 
tone (%) was calculated as [(Dmax − Drest)/Dmax] × 100, where Dmax is the maximum diameter in the 
presence of H2O2 and Drest is the resting control diameter (Table 1). 
Table 1. Middle cerebral artery diameters and resting tone 






SS HS 6 143±11 239±5.1 40±5.2 
SS HS + DDMS 5 127±7.4 236±1.8 46±3.2 
SS HS + Acute Tempol 6 135±8.2 230±2.8 41±3.8 
SS - 5BN HS 6 128±6.3 242±3.9 47±3.2 
DETC - treated SS - 5BN 5 132±6.8 242±3.5 45±3.1 
DETC - treated SS - 5BN + Acute 
Tempol 
4 122±6.7 242±4.5 50±2.7 
DETC - treated SS - 5BN + DDMS 5 152±8.4 243±2.9 37±3.7 
DETC - treated SS - 5BN + Chronic 
Tempol 
5 124±6.3 239±3.2 48±2.6 
DETC - treated SS - 5BN + Chronic 
Tempol + DDMS 
4 131±18.6 239±3.9 45±8.4 
 
Dihydroethidium fluorescence 
Vascular levels of ROS were assessed using DHE fluorescence[ 18] in basilar arteries. Basilar arteries 
were used as a substitute for MCA, as both vessels demonstrate a NO - dependent dilation to ACh,[ 27] 
and the larger diameter of the basilar artery allows for improved cross sectioning. In those 
experiments, isolated arteries were incubated for 30 minutes in PSS heated to 37°C, followed by an 
additional 30 minute incubation with either PSS alone, DDMS (50 μmol/L), PEG ‐ SOD (100 U/mL), or l ‐ 
NAME (100 μmol/L). The vessels were then incubated with DHE (5 μmol/L) for an additional 
15 minutes. The arteries were cut into 10 μm transverse sections and imaged with a Nikon Eclipse 
TS100 microscope (Nikon, Tokyo, Japan) equipped with a ×20 objective, a 540 - nm excitation filter, a 
605 - nm emission filter (Chroma Technology Corp., Bellows Falls, VT) and QImaging Regiga - 2000R 
digital camera (Surrey, British Columbia, Canada). Multiple images of each artery were quantified using 
ImageJ software[ 28] and background fluorescence was subtracted from the fluorescence value of the 
arterial ring.[ 18] 
Western blot 
CYP4A protein expression in cerebral arteries was assessed by western blot using CYP4A1/A2/A3 
antibody (Santa Cruz, sc - 53247), as described previously.[ 11] ,[ 29] ,[ 21] Relative intensity of the 
bands was quantified and normalized to a loading control (β ‐ actin) using a computer ‐ based 
densitometer system and Image - Quant software (Molecular Dynamics). 
Statistical analysis 
Data were summarized as mean ± SEM. For comparisons of two groups, an unpaired Student's t - test 
was used. For all concentration–response curves, differences between multiple groups at each 
concentration were determined using ANOVA, and differences between individual means following 
ANOVA were evaluated using a post hoc Student–Newman–Keuls test. A P<.05 was considered to be 
statistically significant. 
Results 
Vessel diameter and active tone in SS-5BN consomic rats and Dahl SS rats 
Maximum diameter, resting diameter, and active tone in middle cerebral arteries of SS - 5BN consomic 
rats and SS rats are presented in Table 1. Active tone of isolated MCA from SS - 5BN consomic rats was 
unaffected by chronic treatment with either the SOD inhibitor DETC or the SOD mimetic Tempol; and 
there was no effect of acute addition of either Tempol or the CYP4A inhibitor DDMS to the tissue bath. 
Collectively, these findings demonstrate that any differences in the magnitude of vascular relaxation 
responses observed in this study were not due to initial differences in resting tone as a result of a pre - 
existing constriction of the artery or structural differences between treatment groups. 
Responses to acetylcholine in middle cerebral arteries of Dahl SS and SS-5BN consomic 
rats 
Figure 1 summarizes vascular relaxation in response to the endothelium - dependent vasodilator ACh 
in MCA exhibiting myogenic tone from Dahl SS and SS - 5BN consomic rats. MCA from HS - fed Dahl SS 
rats failed to dilate to ACh in control conditions. Vascular relaxation to ACh in MCA of SS rats was 
restored in the presence of either the CYP4A inhibitor DDMS or the superoxide scavenger Tempol 
(Fig. 1A). 
Arteries from HS - fed SS - 5BN consomic rats dilated to ACh in control conditions, but ACh - induced 
dilation was significantly reduced when oxidative stress was artificially elevated by chronic infusion of 
the SOD inhibitor DETC (Fig. 1B). Incubating arteries from DETC - treated SS - 5BN rats with the CYP4A 
inhibitor DDMS restored ACh - induced dilation in those animals. Similar to HS - fed Dahl SS rats, ACh - 
induced relaxation of middle cerebral arteries from DETC - treated SS - 5BN rats was restored either by 
acute incubation with Tempol, or chronic administration of Tempol in the drinking water. Addition of 
DDMS to the tissue bath in the presence of Tempol showed no additive effect (Fig. 1C). 
Vascular oxidative stress in cerebral arteries of Dahl SS rats 
Figure 2 summarizes the ROS levels estimated semiquantitatively via DHE fluorescence in basilar 
arteries from HS - fed Dahl SS rats treated with DDMS, l - NAME, or PEG - SOD. In those experiments, 
both DDMS and l - NAME reduced vascular ROS levels to the same degree as PEG - SOD. 
Vascular oxidative stress in cerebral arteries from SS-5BN consomic rats 
ROS levels in basilar arteries from HS - fed SS - 5BN consomic rats incubated with the CYP4A inhibitor 
DDMS were not significantly different from those in non - treated arteries (Fig. 3), confirming that 
levels of ROS in these arteries were not significantly affected by the CYP4A/20 - HETE pathway. Chronic 
treatment with the SOD inhibitor DETC elevated vascular ROS levels compared to untreated SS - 
5BN consomic rats. Importantly, incubation of basilar arteries from the DETC - treated SS - 5BN consomic 
rats with DDMS restored vascular ROS levels to control values. 
CYP4A enzyme expression in cerebral arteries from Dahl SS and SS-5BN consomic rats 
We have previously shown that CYP4A enzyme expression is lower in SS - 5BN rats fed either NS or HS 
diet compared to SS rats on a similar diet.[ 20] Fig. 4A summarizes the expression of CYP4A enzyme 
protein in cerebral arteries from HS - fed Dahl SS rats in control conditions, during chronic treatment 
with the SOD mimetic Tempol, or chronic cotreatment with Tempol and l - NAME. Treatment with 
Tempol significantly reduced CYP4A protein expression in arteries of Dahl SS rats. Cotreatment with l - 
NAME + Tempol prevented the reduction in CYP4A protein expression in SS rats. In DETC - treated SS - 
5BN consomic rats in which ROS levels were artificially elevated by the SOD inhibitor, chronic treatment 
with Tempol to scavenge superoxide reduced the expression of CYP4A enzyme proteins compared to 
animals that did not receive Tempol (Fig. 4B). 
Discussion 
Reactive oxygen species and the subgroup of oxygen - derived free radicals that includes superoxide 
anion and hydroxyl radical play a key role in the pathogenesis of hypertension.[ 30] ,[ 31] Multiple 
animal models of salt - sensitive hypertension (Dahl SS, stroke prone spontaneously hypertensive rat, 
and mineralocorticoid hypertension), all share in common elevated levels of superoxide anion in either 
the vasculature or the kidney.[ 19] ,[ 32] Dahl SS rats have elevated renal[ 19] ,[ 32] and vascular[ 18] 
,[ 33] superoxide production, and also exhibit reduced renal medullary Cu/Zn - SOD and Mn - SOD 
expression[ 19] and reduced cerebral artery Cu/Zn - SOD expression.[ 18] Other studies[ 20] ,[ 23] have 
shown that Dahl SS rats are vulnerable to the development of vascular dysfunction due to their limited 
antioxidant defense mechanisms. In those studies, vascular function was restored when Cu/Zn - SOD 
expression was upregulated in response to either chronic infusion of a low dose of angiotensin II[ 34] 
or by introgression of a normally functioning Brown Norway renin gene into the SS genetic 
background.[ 18] 
A major component of the deleterious effects of ROS within the vasculature is the reaction between 
nitric oxide and superoxide anion, which not only reduces the bioavailability of nitric oxide, but also 
produces the highly reactive nitrogen species, peroxynitrite.[ 35] Peroxynitrite directly affects vascular 
tone by inhibiting calcium - activated potassium channels[ 36] and alters normal cellular signaling by 
nitration of tyrosine and tryptophan residues.[ 37] ,[ 38] Peroxynitrite is also a significant contributor to 
oxidative stress via eNOS uncoupling due to oxidation of the necessary cofactor BH4 and destruction of 
the heme–heme center of eNOS.[ 39] 
Previous work in our laboratory has shown that acute scavenging of superoxide anions with Tempol, 
which restores nitric oxide bioavailability, restores vasodilator responses to ACh and reduced PO2 in 
cerebral arteries from SS rats.[ 40] Chronic treatment with Tempol in the drinking water also restores 
endothelium - dependent dilation to ACh in arteries of Dahl SS rats, regardless of dietary salt 
intake.[ 41] In this study, chronic scavenging of superoxide radicals with Tempol also ameliorated the 
impaired relaxation in response to ACh in MCA from HS - fed SS rats, presumably by restoring NO 
bioavailability in the vasculature, as the protective effect of chronic Tempol treatment to restore 
acetylcholine - induced dilation in SS rats is eliminated by the NO synthase inhibitor l - NAME.[ 41] 
Taken together, these data are consistent with multiple reports that elevated ROS levels are a major 
contributor to endothelial dysfunction in the Dahl SS rat. 
Previous reports have shown that basilar arteries from Dahl SS rats have elevated levels of vascular 
reactive oxygen species compared to SS - 5BN consomic rats.[ 20] It is interesting to note that vessels 
from the SS - 5BN rat, which shares ~95% genetic homology to the Dahl SS rat, exhibit no differences in 
expression of superoxide dismutase enzymes (Cu/Zn - SOD, MnSOD, or ec - SOD) or endothelial nitric 
oxide synthase compared to Dahl SS rats, regardless of dietary salt intake.[ 20] Based on these findings, 
the reduced antioxidant defenses in Dahl SS rats, leaving them susceptible to vascular assault by ROS, 
should also be present in the SS - 5BN rat. However, the SS - 5BN rat demonstrates normal vascular 
function when fed either a normal salt (0.4% NaCl) or a high - salt diet suggesting that, in addition to 
limited antioxidant defenses, there is an elevated production of ROS in the SS rat compared to the SS - 
5BN rat. 
The CYP4A/20 - HETE pathway appears to be a major contributor to elevated vascular oxidant stress in 
HS - fed SS rats, as arteries from HS - fed Dahl SS rats exhibit a significant reduction in vascular ROS 
levels following incubation with the CYP4A inhibitor DDMS.[ 20] Production of 20 - HETE has the 
capacity to increase vascular ROS via two possible mechanisms: (i) by 20 - HETE - induced NADPH 
oxidase activation[ 42] ,[ 43] ,[ 44] ,[ 45] and (ii) through the uncoupling of eNOS.[ 15] ,[ 14] As noted 
above, 20 - HETE has been shown to directly uncouple eNOS by interfering with the interaction of 
eNOS with HSP90.[ 15] 
In this study, basilar arteries from high - salt - fed Dahl SS rats incubated with l - NAME to inhibit eNOS 
had reduced ROS accumulation to the same degree as vessels treated with either DDMS or the 
superoxide scavenger PEG - SOD. Based on the nearly identical responses of vascular ROS levels to 
DDMS and l - NAME treatment, it is reasonable to postulate that the upregulation of the CYP4A/20 - 
HETE pathway that is present in cerebral arteries of Dahl SS rats[ 20] contributes to oxidative stress via 
uncoupling of eNOS, as vascular ROS levels were reduced to the same degree by treatment with either 
l - NAME or DDMS. Taken together, these observations suggest that 20 - HETE either directly uncouples 
eNOS[ 42] ,[ 43] ,[ 44] ,[ 45] or that the oxidative environment supported by elevated 20 - HETE 
production leads to eNOS uncoupling by another mechanism such as peroxynitrite - induced BH4 
oxidation.[ 39] 
The normal dilation of the MCA in response to ACh in arteries of HS - fed SS - 5BN consomic rats was 
unexpected, and contrasts with the loss of endothelium - dependent dilation in arteries of HS - fed 
Sprague Dawley rats,[ 46] HS - fed SS - 13BN consomic rats,[ 47] and cheek pouch arterioles of HS - fed 
hamsters.[ 48] One important difference between these findings is that HS diet leads to a significant 
increase in vascular ROS levels in HS - fed Sprague Dawley rats[ 22] and hamster arteries,[ 48] but not 
in arteries from HS - fed SS - 5BN rats (Fig. 3). 
In this study, ROS levels in basilar arteries from HS - fed SS - 5BN consomic rats incubated with the 
CYP4A inhibitor DDMS were not significantly different from those in nontreated arteries (Fig. 3), 
confirming that levels of ROS in these arteries were not significantly affected by the CYP4A/20 - HETE 
pathway. Chronic treatment with the SOD inhibitor DETC elevated vascular ROS levels compared to 
untreated SS - 5BN consomic rats. Importantly, incubation of basilar arteries from the DETC - treated SS 
- 5BN consomic rats with DDMS restored vascular ROS levels to control values, supporting the concept 
that the CYP4A/20 - HETE pathway can contribute to vascular ROS production in the cerebral 
circulation. Although unlikely, another possible explanation for the latter finding could be a previously 
unreported effect of the CYP4A inhibitor directly on vascular ROS production. In light of these 
observations, direct measurements of 20 - HETE levels in the presence and absence of DDMS would be 
a valuable direction for future investigation, to exclude any unforeseen off target effects of DDMS. 
Taken together, the findings of this study support the hypothesis that the lower ROS levels in the HS - 
fed SS - 5BN rats are crucial to maintaining the normal endothelium - dependent relaxation of the MCA 
in response to ACh in these animals. Specifically, with lower superoxide levels to combine with and 
degrade nitric oxide, there would be improved NO bioavailability to respond appropriately to 
stimulation by ACh in the SS - 5BN vasculature. While it is tempting to speculate that the lower ROS 
levels and maintained endothelial function in the HS - fed SS - 5BN rats are due to the presence of the 
Brown Norway CYP4A alleles on chromosome 5, it is important to note that the genes coding for CYP4A 
alleles on chromosome 5 are not the only BN genes that may differ from those in the SS rat, which 
could impact the findings of this study. Therefore, a valuable target for future investigation is to 
develop narrowed congenic strains that contain smaller and smaller segments of the BN chromosome 
5 that either include or exclude the BN CYP4A alleles, similar to previously reported studies isolating 
the protective effects chromosome 13 to the presence of a normally functioning BN renin allele in 
narrowed congenic strains derived from SS - 13BN consomic rats.[ 41] 
Chronic treatment with DETC to inhibit superoxide dismutase artificially elevates reactive oxygen 
species in the SS - 5BN rats (Fig. 3), allowing the accumulation of superoxide to go unabated by 
antioxidant defense mechanisms, which would result in superoxide - induced degradation of nitric 
oxide. Consistent with this hypothesis, MCA from DETC - treated SS - 5BN consomic rats failed to dilate 
in response to ACh under control conditions. However, both acute and chronic treatment with Tempol 
to scavenge superoxide restored vascular relaxation in response to ACh in DETC - treated SS - 
5BN consomic rats. Collectively, these observations support the fundamental hypothesis of this study, 
namely that, under conditions of reduced antioxidant defense mechanisms (i.e., in the Dahl SS rat), any 
oxidant - producing pathway contributes to the loss of vascular function. Therefore, inhibiting the 
CYP4A/20 - HETE pathway and reducing vascular oxidative stress would restore NO - dependent 
dilation to ACh in arteries of the SS rats. 
Previous studies in our laboratory[ 49] ,[ 20] have shown that ROS levels, assessed with DHE, are 
significantly lower in cerebral arteries of SS - 5BN rats fed normal salt diet compared to those in SS rats 
fed normal salt diet. Those studies also showed that the expression of CYP4A enzyme protein, assessed 
by western blotting, was also significantly higher in cerebral arteries of SS rats compared SS - 
5BN consomic rats fed either normal or high - salt diet.[ 49] ,[ 20] 
In this study, chronic antioxidant treatment with Tempol significantly reduced CYP4A protein levels in 
cerebral arteries from HS - fed Dahl SS rats and HS - fed SS - 5BN rats treated with the SOD inhibitor 
DETC to artificially elevate superoxide levels compared to arteries from control animals. Cotreatment 
with l - NAME + Tempol prevented the reduction in CYP4A protein expression in SS rats, suggesting 
that the effect of Tempol to reduce the expression of CYP4A enzyme proteins is mediated via 
restoration of nitric oxide bioavailability in the presence of the superoxide scavenger. In DETC - treated 
SS - 5BN consomic rats in which ROS levels were artificially elevated by the SOD inhibitor, chronic 
treatment with Tempol to scavenge superoxide also reduced the expression of CYP4A enzyme proteins 
in SS rats compared to animals that did not receive Tempol (Fig. 4B), again supporting a role for ROS - 
dependent increases in vascular CYP4A protein expression. To our knowledge, this is the first 
demonstration of a regulatory effect of ROS on the expression of CYP4A enzyme proteins. 
The present findings are in contrast to reports from studies of isolated vascular smooth muscle 
cells[ 50] and renal microsomes,[ 51] showing that acute Tempol treatment has no effect on 20 - HETE 
production and that acute addition of high concentrations of a superoxide donor reduces 20 - HETE 
production. However, in those studies, the acute administration of either Tempol or the superoxide 
donor would not allow sufficient time to alter protein expression, as was observed in this study, and 
the use of isolated cells and prepared microsomes may not accurately reflect in vivo conditions. In 
addition, the concentration of superoxide used in those studies was likely high enough to scavenge 20 - 
HETE via lipid peroxidation to form the more polar isoprostane,[ 51] and to reduce the bioavailability of 
necessary cofactors through oxidation, which would substantially reduce 20 - HETE production as 
well.[ 52] ,[ 2] ,[ 44] 
We previously reported that it is possible for reactive oxygen species to exert a regulatory influence 
over the CYP4A/20 - HETE pathway—not directly, but as an indirect result of the effect of superoxide 
on nitric oxide.[ 20] Superoxide anion can affect basal levels of nitric oxide because O2− reacts with NO 
at a rate three times faster than its interaction with SOD.[ 53] In the Dahl SS rat, NO availability in the 
vasculature is reduced due to the elevated vascular ROS.[ 40] ,[ 41] Nitric oxide inhibits CYP4A activity 
by forming a ferrous - nitrosyl complex at the heme binding site of the CYP4A enzyme, presumably 
reducing 20 - HETE production.[ 54] Studies in other laboratories have shown that nitric oxide also has 
the capacity to suppress both mRNA and protein expression of cytochrome P450 enzymes in cultured 
hepatocytes and in liver microsomes,[ 55] ,[ 56] The present studies support a role for NO in regulating 
not only the activity of the CYP4A enzymes, but also the expression of CYP4A protein in the 
vasculature. 
In arteries of HS - fed Dahl SS rats, the inhibitory influence of NO on the CYP4A/20 - HETE pathway 
would be absent due to the ROS - induced degradation of nitric oxide, providing a possible explanation 
for the elevated vascular CYP4A protein expression in arteries of Dahl SS rats compared to those of SS - 
5BN consomic rats.[ 20] Cerebral arteries from HS - fed Dahl SS rats chronically treated with a 
combination of Tempol to scavenge superoxide and the NOS inhibitor l - NAME to prevent the Tempol - 
induced restoration of NO bioavailability had elevated CYP4A protein levels similar to those of the 
control animals (Fig. 4). These data provide compelling evidence that the ROS - induced CYP4A 
upregulation results indirectly from the loss of NO bioavailability and, therefore, removal of NO - 
induced CYP4A inhibition. This novel finding of ROS - induced regulation of CYP4A protein expression 
occurred in both the Dahl SS rat and in the SS - 5BN strain, supporting our hypothesis that oxidative 
stress directly contributes to the upregulation of the CYP4A/20 - HETE pathway. 
A situation where reactive oxygen species stimulate a ROS - producing pathway (the CYP4A/20 - HETE 
pathway) sets the stage for a potentially catastrophic exacerbation of ROS accumulation, especially in 
the presence of limited antioxidant defenses, as present in the Dahl SS rat.[ 18] Taking into 
consideration the necessity of ROS signaling for normal cell survival,[ 2] it is clear that a reduction in 
antioxidant defense mechanisms could result in the pathological oxidant environments observed in 
hypertensive individuals and patients with many other cardiovascular diseases.[ 57] ,[ 31] A positive 
feedback loop involving the CYP4A/20 - HETE pathway provides one possible explanation for the 
spiraling effects of increased ROS production into an advanced disease state, such as hypertension, 
atherosclerosis, and other cardiovascular diseases characterized by endothelial dysfunction. 
Perspectives 
This study used a novel consomic rat strain (the SS - 5BN consomic rat) which is identical to the Dahl salt 
- sensitive (SS) rat genetically except for the introgression of Brown Norway chromosome 5 carrying 
the BN cytochrome P450 - 4A (CYP4A) alleles into the Dahl SS genetic background. The results of this 
study demonstrate not only a role for the CYP4A/20 - HETE pathway in producing ROS (as CYP4A 
inhibition reduced vascular oxidative stress), but also a regulatory influence of vascular free radicals on 
CYP4A protein expression—most likely as a result of reduced nitric oxide bioavailability (as 
manipulation of local ROS levels altered CYP4A protein expression and the beneficial effect of CYP4A 
enzyme inhibition on vascular CYP4A enzyme expression was prevented by inhibiting NOS with l - 
NAME). This potential positive feedback loop between increased CYP4A enzyme expression/activity, 
elevated vascular ROS, reduced NO availability, and elimination of NO - mediated downregulation of 
the CYP4A/20 - HETE system could play a major role in the exacerbation of cardiovascular diseases 
characterized by elevated levels of vascular oxidant stress in humans. 
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Figure 1. Response to acetylcholine in: (A) MCA of Dahl SS (SS) rats fed high salt (HS) diet ± acute addition of 
DDMS (50 µmol/L) or Tempol (100 µmol/L); (B) HS - fed SS - 5BN rats ± chronic DETC (200 mg/kg/day) ± acute 
DDMS; or (C) , HS - fed, chronic DETC - treated SS - 5BN rats ± acute Tempol (100 µmol/L) or ± chronic Tempol 
(15 mg/kg/day) ± acute DDMS (C) (n=4–6 for all groups). Data are expressed as mean change in diameter from 
baseline (µm) ± SEM. *P <.05, significant difference from SS HS (A) or SS - 5BN HS + DETC (B) ; †P <.05, significant 
difference from SS HS + Tempol (A). 
 
 
Figure 2. Vascular reactive oxygen species evaluated by DHE fluorescence in basilar arteries of HS - fed Dahl SS 
rats under either control conditions or incubated with DDMS, L - NAME, or PEG - SOD (n=6 for all groups). Data 
are presented as % of DHE fluorescence (raw fluorescence units) in basilar arteries from HS - fed SS rats. *P <.05, 
significantly different from high salt control. 
 
 
Figure 3. Vascular reactive oxygen species evaluated by DHE fluorescence in basilar arteries of HS - fed SS - 5BN 
consomic rats ± chronic DETC infusion (200 mg/kg/day) in either control conditions (solid bars) or incubated with 
DDMS (open bars) – (n=4–5 for all groups). Data are presented as % of DHE fluorescence (raw fluorescence 
units) in basilar arteries from SS rats fed normal salt (NS; 0.4% NaCl) diet, obtained in initial experiments to 
provide a baseline value for ROS in the unstressed SS parental rat strain in the absence of HS diet. *P <.05, 
significantly different from HS - fed SS - 5BN ± DDMS and DETC - infused SS - 5BN rats + DDMS. 
 
Figure 4. Summary of western blot studies comparing expression of CYP4A enzyme protein in cerebral vessels 
from Dahl SS (SS) rats fed high salt (HS) diet ± Tempol (15 mg/kg/day) or ± Tempol and L - NAME (40 mg/kg/day) 
(A) or SS - 5BN consomic rats infused with DETC (200 mg/kg/day) ± Tempol (B) (n=5 for all groups). Data are 
presented as a % of β ‐ actin loading control. *P <.05, significantly different from other treatment groups in the 
same figure. 
